Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza
24 Articles
24 Articles
Lonza announces that it has signed an agreement for the acquisition of five pharmaceutical subcontracting plants in the United States from German Merck. The total business value is estimated to be around "350 million francs", according to its owner By acquiring five US production sites, which have approximately 1100 employees, Lonza brings its presence in the United States to nine subcontracting manufacturing sites (CDMO) and a workforce of more…
The Darmstädter Dax Group makes a deal in the mid-three-digit million range with the Swiss company Lonza. It is about locations with more than 1000 jobs.
The Darmstädter Dax Group makes a three-digit million-dollar deal with the Swiss company Lonza. Merck thus sharpens its profile. It is about locations with over 1,000 jobs.
The Darmstädter Dax Group makes a three-digit million-dollar deal with the Swiss company Lonza. Merck thus sharpens its profile. It is about locations with over 1,000 jobs.
Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza
Darmstadt, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


















